SG gene therapy startup Nuevocor raises $11.6m additional funding

Nuevocor, a Singapore-headquartered preclinical-stage biotech startup, has raised an additional $11.6 million in funding from existing investors, according to ACRA filings accessed by DealStreetAsia – DATA VANTAGE.